Analysis And Comment
Cardiovascular disease
Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence
BMJ 2006; 333 doi: https://doi.org/10.1136/bmj.39000.486701.68 (Published 23 November 2006) Cite this as: BMJ 2006;333:1114
Related articles
- Paper Published: 26 June 2003; BMJ 326 doi:10.1136/bmj.326.7404.1423
- Paper Published: 23 November 2002; BMJ 325 doi:10.1136/bmj.325.7374.1202
- Research Published: 29 November 2010; BMJ 341 doi:10.1136/bmj.c6273
- PAPERS Published: 10 October 2005; BMJ doi:10.1136/bmj.38611.658947.55
- Paper Published: 03 November 2005; BMJ 331 doi:10.1136/bmj.38611.658947.55
- Feature Published: 14 June 2007; BMJ 334 doi:10.1136/bmj.39232.496227.47
- Paper Published: 13 September 1997; BMJ 315 doi:10.1136/bmj.315.7109.629
See more
- Semaglutide’s CVD indication could cost US Medicare $145bn extra a yearBMJ August 28, 2024, 386 q1878; DOI: https://doi.org/10.1136/bmj.q1878
- Semaglutide: UK regulator approves drug for prevention of cardiovascular eventsBMJ July 25, 2024, 386 q1660; DOI: https://doi.org/10.1136/bmj.q1660
- Why India is failing to track heatstroke fatalities properlyBMJ July 17, 2024, 386 q1437; DOI: https://doi.org/10.1136/bmj.q1437
- Mail on Sunday articles that accused three commentators of being “statin deniers” were misinformed, judge rulesBMJ June 26, 2024, 385 q1424; DOI: https://doi.org/10.1136/bmj.q1424
- Sixty seconds on . . . flyingBMJ June 10, 2024, 385 q1266; DOI: https://doi.org/10.1136/bmj.q1266
Cited by...
- Prospective study of methylenetetrahydrofolate reductase (MTHFR) variant C677T and risk of all-cause and cardiovascular disease mortality among 6000 US adults
- Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial
- Prevalence and effects of gene-gene and gene-nutrient interactions on serum folate and serum total homocysteine concentrations in the United States: findings from the third National Health and Nutrition Examination Survey DNA Bank
- High-Dose Folic Acid Pretreatment Blunts Cardiac Dysfunction During Ischemia Coupled to Maintenance of High-Energy Phosphates and Reduces Postreperfusion Injury
- Reply to EZ Soliman and OA Shalash
- Is folic acid good for everyone?
- Folic Acid Does Not Improve Endothelial Function in Obese Children and Adolescents
- Should folic acid fortification be mandatory? Yes
- Should folic acid fortification be mandatory? No
- Homocysteine and Cardiovascular Risk: Considering the Evidence in the Context of Study Design, Folate Fortification, and Statistical Power
- Prevention of Cardiovascular Disease